Navigation Links
Biodel Awarded NIH Grant to Develop Concentrated Ultra-Rapid-Acting Insulin Formulations for Use in Artificial Pancreas
Date:7/26/2012

d all other Biodel publications associated with this grant are solely the responsibility of Biodel and do not necessarily represent the official views of the National Institutes of Health.

About Biodel Inc.

Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes that may be safer, more effective and more convenient for patients. We develop our product candidates by applying our proprietary formulation technologies to existing drugs in order to improve their therapeutic profiles.

About The SBIR

The Small Business Innovation Research (SBIR) program is a highly competitive program that encourages domestic small businesses to engage in Federal Research/Research and Development (R/R&D) that has the potential for commercialization. Through a competitive awards-based program, SBIR enables small businesses to explore their technological potential and provides the incentive to profit from its commercialization. By including qualified small businesses in the nation's R&D arena, high-tech innovation is stimulated and the United States gains entrepreneurial spirit as it meets its specific research and development needs. 

The mission of the SBIR program is to support scientific excellence and technological innovation through the investment of Federal research funds in critical American priorities to build a strong national economy. The program's goals are four-fold: stimulate technological innovation; meet federal research and development needs; foster and encourage participation in innovation and entrepreneurship by socially and economically disadvantaged persons; and increase private-sector commercialization of innovations derived from federal research and development funding.

Safe-Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
'/>"/>

SOURCE Biodel Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
2. Biodel to Report Second Quarter Fiscal Year 2012 Financial Results on May 10, 2012
3. Biodel Obtains Exclusive License to Aegis Therapeutics Technologies for Development and Commercialization of Glucagon Pharmaceutical Formulations
4. Biodel Announces $18.5 Million Private Placement
5. BioDelivery Sciences Announces Positive Results from BEMA Buprenorphine/Naloxone (BNX) Pharmacokinetic Study
6. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
7. QBC Diagnostics Awarded GSA Contract
8. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
9. Northwest Bio Awarded $5.5 Million German Government Grant
10. Nonin Medical Awarded Novation Contract for Clinically Proven Pulse Oximeters
11. Elsevier / Gold Standards Kay Morgan Awarded NCPCP Highest Honor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013 A decade-long JDRF-funded ... Helmholtz Zentrum München, Germany , is ... and the risk of developing type 1 diabetes (T1D), ... for the disease. The study, "Seroconversion to Multiple Islet ... was published today in The Journal of the ...
(Date:6/19/2013)... , June 19, 2013 The Physician-Patient Alliance for ... fatigue. The need to urgently address this issue ... Sentinel Event Alert #50 , "Medical device alarm safety in ... between January 2008 and June 2012, there were 98 alarm ... in death (82%) , 13 resulted in permanent loss ...
(Date:6/19/2013)... 2013  Caradigm today announced the availability ... to help healthcare organizations efficiently manage clinician ... their compliance with data privacy regulations. The ... in the delivery of advanced role lifecycle ... systems. (Photo: http://photos.prnewswire.com/prnh/20130619/SF34463LOGO ...
Breaking Medicine Technology:New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 2New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 3Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 2Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 3Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 2Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 3
... Oct. 20, 2011 Treating patients with the new ... in significantly higher per patient costs and higher net ... by pharmacy benefit manager Prime Therapeutics (Prime).The study will ... Pharmacy,s Educational Conference in Atlanta, Ga. Dabigatran ...
... today announced publication of a peer-reviewed paper that examines ... for removal of varicose veins in a clinical office ... Powered Phlebectomy in an Office Setting:  Procedural Considerations and ... M.D., FACS (AmeriVein Systems, Aurora, Illinois) and published in ...
Cached Medicine Technology:Study Finds New Blood Thinning Medication, Pradaxa®, Comes at High Cost 2InaVein, LLC Announces First Peer-reviewed Publication of TRIVEX® Used In-Office 2
(Date:6/19/2013)... Kansas City will host its first Ciclovia event on Sept. 7, ... of Main Street in the midtown area will be restricted to ... The Main Street Corridor Development and BikeWalkKC are ... the ranks of dozens of cities across the US and Americas ... and active lifestyles. , “Ciclovia is the perfect event for the ...
(Date:6/19/2013)... Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig,s ... be classified into four distinct stages, report pathologists with ... Pennsylvania in the Annals of Neurology . This ... shows, for the first time, how the fatal degenerative ... central nervous system to other regions of brain and ...
(Date:6/19/2013)... 2013 Ultimate Medical Academy (UMA) participated ... broadcast on WFLA News Channel 8. Since its inaugural ... $84 million for All Children's Hospital in St. Petersburg, ... Years of Miracles," marked the second year UMA volunteered ... worked the phones during the Telethon, which raised a ...
(Date:6/19/2013)... 2013 “We are proud to introduce the ... like it in the U.S.,” says Shaun Johnson, Retail & ... and inexpensive solution to a very expensive problem, considering customers ... fish,” he adds. , Each package of Pond Defender ... the shape of any water garden or pond. The discs ...
(Date:6/19/2013)... the mantra of neurologists treating stroke victims has been "time ... room quickly to receive a drug that dissolves the stroke-causing ... brain tissue is saved or lost. , But ... of giving the intravenous drug known as a tissue ... ischemic (clot-caused), stroke, the most common type of stroke. ...
Breaking Medicine News(10 mins):Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 2Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 3Health News:Staging system in ALS shows potential tracks of disease progression, Penn study finds 2Health News:Ultimate Medical Academy Rallies in Support of All Children's Hospital 2Health News:Ultimate Medical Academy Rallies in Support of All Children's Hospital 3Health News:Timely treatment after stroke is crucial, UCLA researchers report 2Health News:Timely treatment after stroke is crucial, UCLA researchers report 3
... with early rheumatoid arthritis (RA) who are current smokers were ... tumor necrosis factor (TNF) inhibitors than those who never smoked. ... patients who smoked in the past did not experience a ... appear in the January 2011 issue of Arthritis & ...
... is potentially more potent, longer lasting and less ... study led by a Loyola University Health System ... a similar chemical structure to standard morphine. Dr. ... study they performed in rats "demonstrated potential clinical ...
... glaucoma tests requiring a visit to the ophthalmologist could ... by an engineer at the University of Arizona. ... sensors, specially designed microchips, and math-based programmed procedures has ... Engineering. The easy-to-use probe gently rubs the eyelid and ...
... from Virginia Mason Medical Center in Seattle, WA, have ... inappropriate medical imaging, including unnecessary computed tomography (CT) and ... in the January issue of the Journal of ... "Clinical decision support systems are point-of-order decision ...
... clinicians frequently use portable media (CDs, DVDs) to review ... magnetic resonance imaging (MRI) and computed tomography (CT) scans, ... portable media exist, according to a study in the ... College of Radiology ( www.jacr.org ). "Because ...
... DATA SHOWS OMALIZUMAB SAFE AND EFFECTIVE FOR MODERATE TO SEVERE ... New research suggests that subcutaneous omalizumab is safe and effective ... in children and adults. Researchers from Uruguay, Argentina, and Chile ... omalizumab and 1,546 received a placebo. At the end of ...
Cached Medicine News:Health News:Current smokers with early rheumatoid arthritis less responsive to TNF inhibitors, methotrexate 2Health News:Experimental drug more potent, longer lasting than morphine 2Health News:New glaucoma test allows earlier, more accurate detection 2Health News:Study finds problems with reviewing medical images from portable media 2Health News:News briefs from the January issue of Chest 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: